Clinical Trials Logo

Filter by:
NCT ID: NCT01590927 Not yet recruiting - Clinical trials for Pelvic Floor Dyssynergia

Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study

Start date: August 2012
Phase: N/A
Study type: Observational

Now a days the ultrasound is seen as a valid and reliable measurement tool to test the Pelvic Floor Muscle (PFM) movement (Sherburn, Murphy, Carroll, Allen, & Galea, 2005). The hypothesis is that the electromagnetic tracking system, TrakSTARTM, can measure the PFM movement in an equal or even more precise way. The TrakSTARTM will have the advantage to be used in measuring functional movements. In this Master thesis the hypothesis is to show a good reliability by trampoline jumping (physical activity).

NCT ID: NCT01600183 Not yet recruiting - Metatarsus Adductus Clinical Trials

Safety and Efficacy of the Universal Neonatal Foot Orthosis in the Treatment of Metatarsus Adductus (MTA)

Start date: August 2012
Phase: N/A
Study type: Interventional

This is a prospective, randomized, control, open label study in which up to 50 subjects with metatarsus adductus (MTA) will be enrolled. Subjects will be treated with the standard casting or using the UNFO-s device for total time of 20 weeks.

NCT ID: NCT01609699 Not yet recruiting - Clinical trials for Reduction in Abdominal Circumference

Effectiveness Study of the UltraShape® Contour I-Y for Non-Invasive Reduction in Abdominal Circumference

Start date: August 2012
Phase: N/A
Study type: Interventional

The UltraShape® Contour I- Y system uses focused ultrasound to produce localized mechanical motion within fat tissues and cells for the purpose of producing mechanical cellular membrane disruption. It is intended for reduction in body circumference. The primary objective of this study is to evaluate the efficacy of the Contour I - Y System on abdominal circumference reduction relative to baseline pretreatment values using different treatment methods. The primary efficacy endpoint in this trial is Statistical Difference of Circumference reduction between Baseline measurement and at follow-up measurement.

NCT ID: NCT01612390 Not yet recruiting - Clinical trials for Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol

Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

Start date: August 2012
Phase: Phase 0
Study type: Observational

Sublingual misoprostol is superior to oxytocin in reduction of blood loss during the third and fourth stages of labor

NCT ID: NCT01621555 Not yet recruiting - Anomaly; Shoulder Clinical Trials

Pain Sensitivity and Outcome in Arthroscopic Shoulder Surgery

PSOASS
Start date: August 2012
Phase: N/A
Study type: Observational

The purpose of this study is to investigate whether there is a correlation between a patients pain sensitivity and their subsequent post-operative pain and surgical outcome in arthroscopic shoulder surgery.

NCT ID: NCT01621620 Not yet recruiting - Pain Clinical Trials

The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects

Start date: August 2012
Phase: N/A
Study type: Interventional

objectives 1. To study the sympatho-vagal balance effect on different limbs of pain perception. 2. To determine whether it is the hypertension by itself or the baroreflex activation due to blood pressure rise that is responsible for the analgesic effect of acute hypertension. study questions The study questions are derived from the study objectives: 1. Does sympatho-vagal balance influence pain perception? 2. Does sympatho-vagal balance influence diffuse noxious inhibitory control systems? 3. Does sympatho-vagal balance influence temporal summation? 4. Does the hypoalgesic effect to acute increase in blood pressure a result of baroreflex activation?

NCT ID: NCT01623921 Not yet recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma

Start date: August 2012
Phase: N/A
Study type: Interventional

Background: Lung contusion affects 17%-25% of adult blunt trauma patients, and is the leading cause of death from blunt thoracic injury. Statins are lipid-lowering drugs with recently suggested anti-inflammatory and antioxidant properties. Cyclo-oxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins (PG), and evidence suggests that COX-2 plays an important role in the pathogenesis of acute lung injury (ALI). Aims: The current study aims at evaluating the beneficial effects of statins and COX-2 receptor inhibitors on ALI elicited by blunt trauma to the chest. Methods: After approval by the institutional ethics and a scientific committee, and obtaining informed consent , patients admitted to the emergency department (ED) due to blunt trauma with a diagnosis of lung contusion will be enrolled in the study.The effects of statins and COX 2 inhibitors on ALI will be assessed by recording clinical parameters and measuring inflammatory mediators levels in the serum and in the bronchoalveolar space. Expected results: The investigators expect to find that the proposed treatment will be effective in reducing ALI burden. The investigators also suppose that using a combination of those drugs will synergistically potentiate their effect on ALI.

NCT ID: NCT01624064 Not yet recruiting - Clinical trials for Renal Insufficiency, Chronic

Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

CKDu
Start date: August 2012
Phase: Phase 1/Phase 2
Study type: Interventional

Enalapril would significantly reduce progression of renal disease in patients with Chronic Kidney Disease of Uncertain aetiology.

NCT ID: NCT01624519 Not yet recruiting - Clinical trials for Blood Lactate Analysis

Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit

Start date: August 2012
Phase: N/A
Study type: Interventional

The main objective of this study is to examine the agreement between arterial, central venous, and peripheral venous lactate values in a population of medical Intensive Care Unit (ICU) patients.

NCT ID: NCT01630967 Not yet recruiting - Prostate Neoplasm Clinical Trials

Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)

Start date: August 2012
Phase: Phase 2
Study type: Interventional

Men with castrate resistant prostate cancer who are switched from a luteinizing hormone-releasing hormone (LHRH) antagonists from a LHRH agonist will experience a fall in prostate-specific antigen (PSA).